VCEL

#2058
Vericel Corporation
35.1400 USD
+2.03%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
35.1400
35.1400
1年のレンジ
28.9500
43.0000
1日の変化
+2.03%
月次変化
+7.17%
6か月変化
-3.33%
1年の変化
-3.33%
以前の終値
34.4400
始値
35.1400
Bid
Ask
安値
35.1400
High
35.1400
ボリューム
65
チャート全体を表示

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 1.7838 B
  • Employee 398
  • Founded 1989
  • CEO Nick Colangelo
  • Website www.vcel.com
  • Headquarter Michigan, United States
  • FIGI BBG000BDCM24
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
112.53
売上高対価格比率
6.8

Vericel Corporation

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan. In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before. In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts.

ニュース